127 related articles for article (PubMed ID: 5880932)
1. [Coagulation disorders without hemorrhagic diathesis due to delayed aggregration of fibrin molecules].
von Felten A; Duckert F; Frick P
Schweiz Med Wochenschr; 1965 Oct; 95(43):1453-6. PubMed ID: 5880932
[No Abstract] [Full Text] [Related]
2. "Fibrinogen Tokyo II". An abnormal fibrinogen with an impaired polymerization site on the aligned DD domain of fibrin molecules.
Matsuda M; Baba M; Morimoto K; Nakamikawa C
J Clin Invest; 1983 Sep; 72(3):1034-41. PubMed ID: 6886002
[TBL] [Abstract][Full Text] [Related]
3. Fibrinogen Amsterdam, another hereditary abnormality of fibrinogen.
Janssen CL; Vreeken J
Br J Haematol; 1971 Mar; 20(3):287-98. PubMed ID: 4101579
[No Abstract] [Full Text] [Related]
4. [Familial dysfibrinogenemia with abnormal nonomer aggregation. Paris III fibrinogen].
Soria J; Soria C
Pathol Biol (Paris); 1974 Nov; 22 suppl():72-9. PubMed ID: 4620099
[No Abstract] [Full Text] [Related]
5. [Abnormalities of fibrin formation in benign viral hepatitis (author's transl)].
Thabaut A; Laverdant C; Durosoir JL; Cristau P; Essioux J; Molinié C
Ann Med Interne (Paris); 1979; 130(1):35-8. PubMed ID: 434713
[TBL] [Abstract][Full Text] [Related]
6. Fibrin and cancer.
Costantini V; Zacharski LR
Thromb Haemost; 1993 May; 69(5):406-14. PubMed ID: 8322261
[No Abstract] [Full Text] [Related]
7. [Hemorrhagic diathesis with dominant heredity, caused by an abnormal fibrinogen (fibrinogen Baltimore)].
Beck EA; Mosesson MW; Charache P; Jackson DP
Schweiz Med Wochenschr; 1966 Sep; 96(37):1196-9. PubMed ID: 5996847
[No Abstract] [Full Text] [Related]
8. Blood coagulation abnormalities associated with envenoming by Trimeresurus albolabris in Hong Kong.
Chan JC; Kwok MM; Cockram CS; Prematilleke MN; Tomlinson B; Critchley JA
Singapore Med J; 1993 Apr; 34(2):145-7. PubMed ID: 8266156
[TBL] [Abstract][Full Text] [Related]
9. [Unexpectedly prolonged thrombin time].
Barth A; Furlan M; Lämmle B
Schweiz Med Wochenschr; 1993 Mar; 123(12):523-9. PubMed ID: 8475358
[TBL] [Abstract][Full Text] [Related]
10. [Blood coagulation disorders caused by genetic variants of fibrinogen].
Fiedler H
Z Arztl Fortbild (Jena); 1970 Sep; 64(18):913-8. PubMed ID: 4922245
[No Abstract] [Full Text] [Related]
11. [A new case of Congenital and familial dysfibrinogenemia without Hemorrhagic Diathesis].
Streiff F; Alexandre P; Vigneron C; Soria J; Soria C; Mester L
Thromb Diath Haemorrh; 1971 Dec; 26(3):565-76. PubMed ID: 4947421
[No Abstract] [Full Text] [Related]
12. [Acanthocytosis of red blood cells. A case during hepatic cirrhosis with hemolysis and defibrination].
Gorin NC; Gouault M; Rochan H; Dreyfus B
Nouv Presse Med; 1975 Jan; 04(2):101-4. PubMed ID: 1138219
[No Abstract] [Full Text] [Related]
13. [Fibrinogen and fibrin degradation products (FDP) in hepatic cirrhosis].
Buraschi J; Sack ES
Sangre (Barc); 1972; 17(1):35-42. PubMed ID: 5016795
[No Abstract] [Full Text] [Related]
14. [Immunoelectrophoretic study of fibrinogen and of degradation products of fibrinogen and fibrin].
Karpinskaia VM
Probl Gematol Pereliv Krovi; 1968 Jan; 13(1):53-6. PubMed ID: 5736826
[No Abstract] [Full Text] [Related]
15. Fibrinogen and dysfibrinogenemia.
Morse EE
Ann Clin Lab Sci; 1980; 10(4):351-5. PubMed ID: 7447388
[TBL] [Abstract][Full Text] [Related]
16. [Fibrinogenopathies].
Stahl M
Acta Haematol Pol; 1972; 3(1):93-9. PubMed ID: 4568055
[No Abstract] [Full Text] [Related]
17. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. III. Demonstration of abnormal clot structure by electron microscopy.
BANG NU; FLETCHER AP; ALKJAERSIG N; SHERRY S
J Clin Invest; 1962 Apr; 41(4):935-48. PubMed ID: 13864646
[No Abstract] [Full Text] [Related]
18. [Anomalies of fibrin formation in benign viral hepatitis].
Thabaut A; Laverdant C; Durosoir JL; Cristau P; Essioux H; Molinie C
Med Chir Dig; 1978; 7(7):555-7. PubMed ID: 755141
[No Abstract] [Full Text] [Related]
19. Fibrinogen Caracas I: a dysfibrinogenemia with a hemorrhagic diathesis associated with diminished fibrin fiber diameter and reduced fibrin gel porosity.
Marchi R; Lundberg U; de Bosch NB; Arocha-Piñango CL
Blood Coagul Fibrinolysis; 1998 Nov; 9(8):733-9. PubMed ID: 9890716
[TBL] [Abstract][Full Text] [Related]
20. "Dirty" fiber--"clean" fiber: a theory of the organization of fibrin from fibrinogen.
Branson HE
Thromb Haemost; 1980 Feb; 42(5):1378-87. PubMed ID: 7368145
[No Abstract] [Full Text] [Related]
[Next] [New Search]
